Biotechnology
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$40.2M
10 rounds on record
Latest round
$6.9M
Convertible Note · Mar 2026 · 7 mo ago
Team
51-200
employees, estimated range
Grants
$8M
4 grants · CORDIS
The money's age
Fresh money
7 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 24
Raised a round Convertible Note $6.9M · SEC Form D
Oct 30, 2025
Raised a round Venture round $6.9M · SEC Form D
Sep 8, 2023
Won a grant $1.8M · CORDIS
Dec 28, 2022
Raised a round Venture round $12.8M · SEC Form D
Sep 15, 2022
Won a grant $3.4M · CORDIS
Apr 1, 2022
Raised a round Convertible Note $4M · SEC Form D
Sep 30, 2020
Won a grant $2.5M · CORDIS
Aug 26, 2020
Board appointment Jean-Pierre Million, Director · SEC Form D
Apr 15, 2019
Won a grant $300k · CORDIS
2017
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Convertible Note | Mar 2026 | $6.9M | — | SEC Form D |
| Venture round | Oct 2025 | $6.9M | — | SEC Form D |
| Grant | Sep 2023 | $1.8M | — | CORDIS |
| Venture round | Dec 2022 | $12.8M | — | SEC Form D |
| Grant | Sep 2022 | $3.4M | — | CORDIS |
| Convertible Note | Apr 2022 | $4M | — | SEC Form D |
| Grant | Sep 2020 | $2.5M | — | CORDIS |
| Venture round | Aug 2020 | $4M | — | SEC Form D |
| Venture round | Jun 2019 | $5.8M | — | SEC Form D |
| Grant | Apr 2019 | $300k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | Alume Biosciences Inc | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Kaveri ParkerExecutive OfficerSEC Form D
Brett BermanExecutive Officer, DirectorSEC Form D
James SchmidtExecutive OfficerSEC Form D
Quyen NguyenExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Preactiv - An innovative platform that optimises patients before surgery using technology to create individualised prehabilitation…

Solstice Oncology is a clinical stage immuno-oncology company developing a therapeutic that meets cancer at its most vulnerable moment…

Advanced Absorbable Metal TechnologyThe Next Standard of Care in Surgery Fixation. At Entirety Biomedical, we are passionate in our pursuit…

A smarter surgical platform. We're building the intelligence layer for surgery, starting with endourology.

Surgify develops new solutions to protect these structures and prevent associated complications. Bleeding, infections and nerve injuries…

Driving Cost Savings. StreamliningSupply Chains.. Surgery Stuff is a trusted provider of high-quality surgical supplies for hospitals and…
People

Kaveri Parker
Executive Officer

Brett Berman
Executive Officer, Director

James Schmidt
Executive Officer

Quyen Nguyen
Executive Officer, Director

Magda Marquet
Director

Kim Kamdar
Director

Jean-Pierre Millon
Director

Dan Bradbury
Director

Jean-Pierre Million
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
San Diego
United States
HQ
La Jolla
United States
Regional office
Hear more from our leaders and about Alume's technology
2223 Avenida de La Playa, Suite 205, La Jolla, CA 92037
Financials
Total raised
$48.2M
Latest round
Convertible Note
Funding rounds
10
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Convertible Note | 2026 | $6.9M | Details |
| Venture - Series Unknown | 2025 | $6.9M | Details |
| Grant | 2023 | $1.8M | Details |
| Venture - Series Unknown | 2022 | $12.8M | Details |
| Grant | 2022 | $3.4M | Details |
| Convertible Note | 2022 | $4M | Details |
| Grant | 2020 | $2.5M | Details |
| Venture - Series Unknown | 2020 | $4M | Details |
| Venture - Series Unknown | 2019 | $5.8M | Details |
| Grant | 2019 | $300k | Details |






